Bicocca Open Archive

Logo unimib boa
CANTA, ANNALISA ROSANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.308
AS - Asia 13.802
EU - Europa 9.079
SA - Sud America 1.608
AF - Africa 310
OC - Oceania 80
Continente sconosciuto - Info sul continente non disponibili 25
Totale 43.212
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.830
SG - Singapore 4.654
CN - Cina 2.793
VN - Vietnam 2.673
IT - Italia 1.608
DE - Germania 1.571
HK - Hong Kong 1.467
RU - Federazione Russa 1.298
BR - Brasile 1.202
SE - Svezia 1.072
IE - Irlanda 840
GB - Regno Unito 558
UA - Ucraina 552
IN - India 450
FR - Francia 449
KR - Corea 337
CA - Canada 322
FI - Finlandia 267
ID - Indonesia 205
BD - Bangladesh 194
JP - Giappone 170
AR - Argentina 156
AT - Austria 155
TR - Turchia 146
IQ - Iraq 127
NL - Olanda 124
ZA - Sudafrica 104
MX - Messico 101
ES - Italia 98
PK - Pakistan 96
PL - Polonia 87
DK - Danimarca 80
LT - Lituania 80
SA - Arabia Saudita 62
CH - Svizzera 60
AU - Australia 59
PH - Filippine 55
BE - Belgio 53
EC - Ecuador 52
CO - Colombia 49
IR - Iran 46
VE - Venezuela 46
MY - Malesia 40
EG - Egitto 39
CL - Cile 33
UZ - Uzbekistan 32
PY - Paraguay 29
AE - Emirati Arabi Uniti 28
MA - Marocco 28
TW - Taiwan 28
KZ - Kazakistan 25
RO - Romania 25
TN - Tunisia 25
ET - Etiopia 24
KE - Kenya 24
IL - Israele 23
EU - Europa 20
JO - Giordania 18
NZ - Nuova Zelanda 18
TH - Thailandia 18
NP - Nepal 17
BO - Bolivia 14
DZ - Algeria 14
OM - Oman 14
UY - Uruguay 14
AO - Angola 13
AZ - Azerbaigian 13
CZ - Repubblica Ceca 13
PS - Palestinian Territory 12
BG - Bulgaria 11
PE - Perù 11
PT - Portogallo 11
CR - Costa Rica 9
HR - Croazia 9
KG - Kirghizistan 9
LB - Libano 9
AL - Albania 8
BH - Bahrain 8
HU - Ungheria 8
JM - Giamaica 7
MD - Moldavia 7
NG - Nigeria 7
PA - Panama 7
RS - Serbia 7
GR - Grecia 6
KW - Kuwait 6
NI - Nicaragua 6
SN - Senegal 6
CI - Costa d'Avorio 5
DO - Repubblica Dominicana 5
HN - Honduras 5
NO - Norvegia 5
SK - Slovacchia (Repubblica Slovacca) 5
LV - Lettonia 4
SY - Repubblica araba siriana 4
TT - Trinidad e Tobago 4
BN - Brunei Darussalam 3
BY - Bielorussia 3
GE - Georgia 3
LY - Libia 3
Totale 43.150
Salva come PNG Salva come JPEG
Città #
Singapore 2.899
Ann Arbor 2.460
Ashburn 1.534
Dallas 1.497
Hong Kong 1.408
San Jose 1.308
Woodbridge 854
Dublin 820
Chandler 808
Ho Chi Minh City 802
Frankfurt am Main 778
Houston 645
Milan 641
Hanoi 631
Wilmington 551
Jacksonville 540
New York 504
Fairfield 480
Dearborn 436
Beijing 418
Santa Clara 400
Los Angeles 389
Chicago 291
Princeton 282
Hefei 273
Seoul 255
The Dalles 228
Seattle 225
Council Bluffs 212
Boardman 202
Nanjing 190
Shanghai 173
Lauterbourg 162
Buffalo 149
Cambridge 142
Jakarta 141
Vienna 136
Helsinki 120
São Paulo 115
Guangzhou 109
Moscow 107
Orem 105
Munich 91
Da Nang 89
Lachine 84
Tokyo 82
Lawrence 81
Dong Ket 77
Altamura 74
Haiphong 74
Chennai 69
Toronto 67
Nanchang 60
Shenyang 60
London 59
Vilnius 57
Denver 55
Baghdad 53
Ha Long 52
Hải Dương 52
Pune 52
Montreal 50
Warsaw 50
Andover 49
Carate Brianza 49
Rome 49
Nuremberg 48
Phoenix 48
Amsterdam 47
Atlanta 46
Biên Hòa 46
Grafing 45
Johannesburg 45
Zurich 45
Brooklyn 43
Can Tho 43
Changsha 43
Stockholm 43
Falls Church 42
Jinan 41
San Diego 41
Fremont 40
Basingstoke 38
Bắc Ninh 38
Zhengzhou 38
Brussels 37
Rio de Janeiro 37
Tianjin 37
Dhaka 35
Jiaxing 35
Ninh Bình 35
Nürnberg 35
Poplar 35
Hangzhou 34
San Francisco 34
Columbus 32
Kunming 32
Manchester 32
Vũng Tàu 32
Mexico City 31
Totale 27.288
Salva come PNG Salva come JPEG
Nome #
ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier 598
CIPN and its mechanism of development 595
Paclitaxel alters the microvascular network in the central and peripheral nervous system of rats with chemotherapy-induced painful peripheral neuropathy 570
Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: the role of nerve excitability testing 499
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 490
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 445
Effect of age on metabolomic changes in a model of paclitaxel‐induced peripheral neurotoxicity 440
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 416
Age-related changes in the function and structure of the peripheral sensory pathway in mice 412
Angiogenesis-Related New Mechanisms for Chemotherapy-Induced Painful Peripheral Neuropathy in the Rat 410
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 404
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 400
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 390
Enhanced brain targeting of engineered solid lipid nanoparticles 388
Effect of age on metabolomic changes in a model of paclitaxel-induced neurotoxicity 386
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 378
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 368
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 367
CENTRAL AND PERIPHERAL MICROVASCULAR NETWORK IS ABNORMAL IN RATS WITH PAINFUL-CHEMOTHERAPY INDUCED NEUROPATHY: NEW PATHOPHYSIOLOGICAL MECHANISMS OVER THE HORIZON? 353
Investigation of Supraspinal Plasticity in a Rat Model of Painful Paclitaxel-induced Peripheral Neuropathy 352
Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats 344
Neutrophil depletion affects Dark Agouti Experimental Autoimmune Encephalomyelitis 344
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 339
ITF6475, a New Histone Deacetylase 6 Inhibitor, Prevents Painful Neuropathy Induced by Paclitaxel 338
Sox2 deficiency causes neurodegeneration and impaired neurogenesis in the adult mouse brain 333
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 331
Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation 328
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 315
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 309
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 307
Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats 306
Bortezomid-induced peripheral neurotoxicity: A neurophysiological and pathological study in the rat. 306
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 305
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 303
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity 299
Translation of paclitaxel-induced peripheral neurotoxicity from mice to patients: the importance of model selection 299
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 297
Effects of Islet Transplantation and Mesenchymal Stem Cell Co-Transplantation in the Protection of Diabetic Neuropathy in Streptozotocin-Induced Diabetic Rats 295
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 295
Dorsal Root Ganglia Neurons Morphometry Analysing Method Optimization 294
Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy 294
Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity 289
In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™) 289
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 289
EVALUATION OF SATELLITE GLIAL CELLS CHANGES IN DORSAL ROOT GANGLIA IN CHEMOTHERAPY-INDUCED NEUROTOXICITY MODELS 288
Exposure-response relationship of the synthetic epothilone sagopilone in a peripheral neurotoxicity rat model 288
Bortezomib-Induced Peripheral Neurotoxicity: a Preclinical Model to Study Neuropathic Pain in Rat 287
Cisplatin-induced peripheral neuropathy: neuroprotection by erythropoietin without affecting tumour growth 285
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 285
Insight Into Chemotherapeutic-Agents-Induced-Neuroinflammation In Rat Experimental Neuropathies 283
Expression and distribution of 'high affinity' glutamate transporters GLT1, GLAST, EAAC1 and of GCPII in the rat peripheral nervous system 283
Topiramate possible double efficacy profile: Oxaliplatin-induced peripheral neurotoxicity prevention and anticancer synergic action 282
OCT2 transporter involvement in development of cisplatin toxicity 281
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 278
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells 277
The ventral caudal nerve: a physiologic-morphometric study in three different rat strains 276
In vivo study of Carfilzomib-Induced Neuropathy 275
NCX2 modulation to prevent axonal damage related to Oxaliplatin-induced peripheral neurotoxicity 273
Morphological and functional study of the caudal nerve in a rat model of peripheral neuropathy 273
Enhanced brain targeting of engineered solid lipid nanoparticles 269
Tubulin: a target for antineoplastic drugs into the cancer cells but also in the peripheral nervous system 268
Molsidomide provides neuroprotection against vincristine-induced peripheral neurotoxicity 268
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 268
Morphological and functional assessment of NCX2 potential role in axonal damage related to Oxaliplatin 267
Effects of different erythropoietin schedules in cisplatin-induced peripheral neurotoxicity 265
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 264
Effect of proteasome inhibition on the central and peripheral nervous system 262
Intraepidermal nerve fiber density in rat foot pad: Neuropathologic- neurophysiologic correlation 261
Multimodal experimental approach to the study of human neurological diseases 260
Oxaliplatin induced peripheral neurotoxicity (OIPN) and ion unbalance: the perilous link between acute and chronic neurotoxicity. 259
NEUROINFLAMMATION AS A POTENTIAL TARGET FOR CIPN DIAGNOSTIC AND TREATMENT 255
MORPHOLOGICAL AND METABOLOMIC CHANGES IN PIPN 254
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 254
Satellite Glial Cells in Chemotherapy Induced Peripheral Neuropathy 253
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 253
Bortezomib-induced peripheral neurotoxicity: A neurophysiological study in a rat model 251
Continuous Buprenorphine Delivery Effect in Streptozotocine-Induced Painful Diabetic Neuropathy in Rats 246
Experimental epothilone B neurotoxicity: Results of in vitro and in vivo studies 245
Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy 244
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 244
Genetic factors influencing the development of vincristine-induced neurotoxicity 244
Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies 243
Cr4056: a novel potent anti-nociceptive agent for several animal models of neuropathic pain 243
A new animal model of chemotherapy induced peripheral neurotoxicity : the immunodeficient mouse 243
Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity 241
Antibody Against Tumor Necrosis Factor-α Reduces Bortezomib-induced Allodynia in a Rat Model 241
Neutrophil depletion during sensitization phase affects the chronic phase of Experimental Autoimmune Encephalomyelitis 238
Characterization in vivo of two different molecular mechanisms involved in the development of bortezomib-induced peripheral neuropathy 238
Central and peripheral neoangiogenesis in paclitaxel-induced painful peripheral neuropathy 238
Inhibition of NHE1 transport activity and gene transcription in DRG neurons in oxaliplatin-induced painful peripheral neurotoxicity 237
Transplanted pancreatic islets survive and reverse type I diabetic neuropathy 237
Studying the caudal nerve anatomy and physiology to refine detection of peripheral nerve damage in rodent models. 237
Paclitaxel: Chemotherapy and Neurotoxicity – The Two sides of the Coin 236
Toward the identification of neuroprotective agents: G-scale synthesis, pharmacokinetic evaluation and CNS distribution of (R)-RC-33, a promising SIGMA1 receptor agonist 236
Valproate protective effects on cisplatin-induced peripheral neuropathy: An in vitro and in vivo study 235
Platinum-taxane combination chemotherapy: Description of the first study to assess the general and peripheral neurotoxicity of their combined administration in the rat 234
Characterization of bortezomib-induced peripheral neuropathy in an immune-suppressed murine model 234
ANALGELSIC EFFECT OF BUPRENORPHINE IN AN EXPERIMENTAL MODEL OF PAINFUL DIABETIC PERIPHERAL NEUROPATHY 234
Chemotherapy-induced allodinia: Neuroprotective effect of acetyl-L-carnitine 232
BEHAVIOURAL AND MORPHOLOGICAL DESCRIPTION OF BORTEZOMIB-INDUCED PAINFUL NEUROPATHY IN RATS 232
Totale 30.486
Salva come PNG Salva come JPEG
Categoria #
all - tutte 132.678
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 132.678
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021461 0 0 0 0 0 0 0 0 0 0 178 283
2021/20221.893 132 194 143 200 168 212 91 89 91 133 144 296
2022/20233.477 363 887 321 358 276 535 61 176 277 56 103 64
2023/20242.911 97 106 106 134 345 709 519 176 136 65 65 453
2024/20257.357 385 826 683 331 581 305 500 256 772 977 618 1.123
2025/202618.611 2.714 1.793 2.375 1.710 1.845 1.084 2.734 977 1.569 1.676 134 0
Totale 44.372